Penn Medical Researchers Dispute the Efficacy of a Breast Cancer Treatment

PHILADELPHIA -- Researchers at the University of Pennsylvania’s Perelman School of Medicine are suggesting that a prophylactic treatment option increasingly offered to breast cancer patients has only a slight benefit, and the modest gains to life expectancy the treatment provides may actually be offset by decreases in quality of life for many patients.

Katie Delach